Sana Biotechnology, Inc.

Sana Biotechnology trades at a discount despite promising early T1D treatment data and limited cash runway.
Pluang · 13 Oct 2026
Sana Biotechnology: A Shot At Diabetes
Seeking Alpha · 13 Oct 2026
Form 4 Sana Biotechnology Inc For: 11 October By Investing.com
Investing.com Canada · 11 Oct 2026
Form 4 Sana Biotechnology Inc For: 11 October By Investing.com
Investing.com South Africa · 11 Oct 2026
SANA Q2 2026 Earnings: Wider-Than-Expected Loss Keeps Focus on Cash Discipline - Earnings Season Preview
https://www.dars.gov.et/ · 08 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.